AB-Kefir probiotics ameliorate dyslipidaemia and endothelial dysfunction in high-fat diet-induced obese rats
References
- Abd-Alwahab, W., & Al-Dulaimi, F. (2018). Effects of kefir as a probiotic on total lipid profile and activity of aspartate amino transferase and alanine amino transferase in serum of human. Biochemical and Cellular Archives, 18, 411–414. https://doi.org/10.13140/RG.2.2.16238.25928
- Abdi, M., Esmaeili, H., Ghaleh, G., & Ranjbar, R. (2022). Lactobacilli and Bifidobacterium as anti-atherosclerotic agents. Iranian Journal of Basic Medical Sciences, 25, 934–946. https://doi.org/10.22038/IJBMS.2022.63860.14073
- Aggarwal, J., Swami, G., & Kumar, M. (2013). Probiotics and their effects on metabolic diseases: An update. Journal of Clinical and Diagnostic Research, 7, 173–177. https://doi.org/10.7860/JCDR/2012/5004.2701
- Akar, F., Sumlu, E., Alçığır, M.E., Bostancı, A., & Sadi, G. (2021). Potential mechanistic pathways underlying intestinal and hepatic effects of kefir in high-fructose-fed rats. Food Research International, 143, 110287. https://doi.org/10.1016/j.foodres.2021.110287
- Akther, F., Razan, R., Shaligram, S., Graham, J. L., Stanhope, K. L., Allen, K. N., Vázquez-medina, J. P., Havel, P. J., & Rahimian, R. (2021). Potentiation of acetylcholine-induced relaxation of aorta in male UC Davis type 2 diabetes mellitus (UCD-T2DM) rats: Sex-specific responses. Frontiers in Physiology, 12, 616317. https://doi.org/10.3389/fphys.2021.616317
- Angelis-Pereira, M. C. D., Barcelos, M. D. F. P., Sousa, M. S. B., & Pereira, J. D. A. R. (2013). Effects of the kefir and banana pulp and skin flours on hypercholesterolemic rats. Acta Cirurgica Brasileira, 28, 481–486. https://doi.org/10.1590/S0102-86502013000700001
- Asemi, Z., Zare, Z., Shakeri, H., Sabihi, S. S., & Esmaillzadeh, A. (2013). Effect of multispecies probiotic supplements on metabolic profiles, hs-CRP, and oxidative stress in patients with type 2 diabetes. Annals of Nutrition and Metabolism, 63, 1–9. https://doi.org/10.1159/000349922
- Azemi, A. K., Mokhtar, S. S., Hou, L. J., Sharif, S. E. T., & Rasool, A. H. G. (2021). Model for type 2 diabetes exhibits changes in vascular function and structure due to vascular oxidative stress and inflammation. Biotechnic and Histochemistry, 96, 498–506. https://doi.org/10.1080/10520295.2020.1823480
- Azizi, N. F., Kumar, M. R., Yeap, S. K., Abdullah, J. O., Khalid, M., & Alitheen, N. B. (2021). Kefir and its biological activities. Foods, 10(6), 1210. https://doi.org/10.3390/foods10061210
- Bagi, Z., Feher, A., & Cassuto, J. (2012). Microvascular responsiveness in obesity: Implications for therapeutic intervention. British Journal of Pharmacology, 165, 544–560. https://doi.org/10.1111/j.1476-5381.2011.01606.x
- Bellikci-koyu, E., Sarer-yurekli, B. P., Karagozlu, C., Aydin-kose, F., Ozgen, A. G., & Buyuktuncer, Z. (2022). Probiotic kefir consumption improves serum apolipoprotein A1 levels in metabolic syndrome patients: A randomized controlled clinical trial. Nutrition Research, 102, 59–70. https://doi.org/10.1016/j.nutres.2022.02.006
- Bourrie, B. C. T., Willing, B. P., & Cotter, P. D. (2016). The microbiota and health promoting characteristics of the fermented beverage kefir. Frontiers in Microbiology, 7, 647. https://doi.org/10.3389/fmicb.2016.00647
- Bourrie, B. C. T., Cotter, P. D., & Willing, B. P. (2018). Traditional kefir reduces weight gain and improves plasma and liver lipid profiles more successfully than a commercial equivalent in a mouse model of obesity. Journal of Functional Foods, 46, 29–37. https://doi.org/10.1016/j.jff.2018.04.039
- Bourrie, B. C. T., Richard, C., & Willing, B. P. (2020). Kefir in the prevention and treatment of obesity and metabolic disorders. Current Nutrition Reports, 9, 184–192. https://doi.org/10.1007/s13668-020-00315-3
- Brasil, G. A., Silva-Cutini, M. A., Moraes, F. S. A., Pereira, T. M. C., Vasquez, E. C., Lenz, D., & de Andrade, T. U. (2018). The benefits of soluble non-bacterial fraction of kefir on blood pressure and cardiac hypertrophy in hypertensive rats are mediated by an increase in baroreflex sensitivity and decrease in angiotensin-converting enzyme activity. Nutrition, 51–52, 66–72. https://doi.org/10.1016/j.nut.2017.12.007
- Chen, H. L., Tsai, T. C., Tsai, Y. C., Liao, J. W., Yen, C. C., & Chen, C. M. (2016). Kefir peptides prevent high-fructose corn syrup-induced non- alcoholic fatty liver disease in a murine model by modulation of inflammation and the JAK2 signaling pathway. Nutrition & Diabetes, 6, e237. https://doi.org/10.1038/nutd.2016.49
- Chen, Y., Guan, W., Zhang, N., Wang, Y, Tian, Y., Sun, H., Li, X., Wang, Y, & Liu, J. (2022). Lactobacillus plantarum Lp2 improved LPS-induced liver injury through the TLR-4/MAPK/NFκB and Nrf2-HO-1/CYP2E1 pathways in mice. Food & Nutrition Research, 66, 5459. https://doi.org/10.29219/fnr.v66.5459
- Chen, Y.-T.; Hsu, A.-H., Chiou, S.-Y., Lin, Y.-C., & Lin, J.-S. (2021). AB-kefir reduced body weight and ameliorated inflammation in adipose tissue of obese mice fed a high-fat diet, but not a high-sucrose diet. Nutrients, 13, 2182. https://doi.org/10.3390/nu13072182
- Cheng, C., Tsai, S., Chiu, C., Pan, T., & Tsai, T. Y. (2013). The effect of probiotic-fermented soy milk on enhancing the NO-mediated vascular relaxation factors. Journal of Science and Food Agriculture, 93, 1219–1225. https://doi.org/10.1002/jsfa.5880
- Choi, J., Kang, H. W., Lim, W., Kim, M., Lee, I., & Cho, H. (2017). Kefir prevented excess fat accumulation in diet-induced obese mice. Bioscience Biotechnology and Biochemistry, 81, 958–965. https://doi.org/10.1080/09168451.2016.1258984
- Chong, B., Jayabaskaran, J., Jauhari, S. M., Chan, S. P., Goh, R., Kueh, M. T. W., Li, H., Chin, Y. H., Kong, G., Anand, V. V., Wang, J.-W., Muthiah, M., Jain, V., Mehta, A., Lim, S. L., Foo, R., Figtree, G. A., Nicholls, S. J., Mamas, M. A., Januzzi, J. L., Chew, N. W. S., Richards, A. M., & Chan, M. Y. (2025). Global burden of cardiovascular diseases: projections from 2025 to 2050. European Journal of Preventive Cardiology, 32, 1001–1115. https://doi.org/10.1093/eurjpc/zwae281
- Di Cesare, M., Perel, P., Taylor, S., Kabudula, C., Bixby, H., Gaziano, T. A., McGhie, D. V., Mwangi, J., Pervan, B., Narula, J., Pineiro, D., & Pinto, F. J. (2024). The heart of the world. Global Heart, 19, 11 https://doi.org/10.5334/gh.1288
- Dinh, Q., Drummond, G., Sobey, C., & Chrissobolis, S. (2014). Roles of inflammation, oxidative stress, and vascular dysfunction in hypertension. BioMed Research International, 2014, 406960. https://doi.org/10.1155/2014/406960
- Dixon, A., Robertson, K., Yung, A., Que, M., Randall, H., & Wellalagodage, D. (2020). Efficacy of probiotics in patients of cardiovascular disease risk: A systematic review and meta-analysis. Current Hypertension Reports, 22, 74. https://doi.org/10.1007/s11906-020-01080-y
- Ettinger, G., MacDonald, K., Reid, G., & Burton, J. (2014). The influence of the human microbiome and probiotics on cardiovascular health. Gut Microbes, 5, 719–728. https://doi.org/10.4161/19490976.2014.983775
- Farag, M. A., Jomaa, S. A., Abd El-Wahed, A., & El-Seedi, H. R. (2020). The many faces of kefir fermented dairy products: Quality characteristics, flavour chemistry, nutritional value, health benefits, and safety. Nutrients, 12, 346. https://doi.org/10.3390/nu12020346
- Friques, Andreia G. F., Arpini, C. M., Kalil, I. C., Gava, A. L., Leal, M. A., Porto, M. L., Nogueira, B. V., Dias, A. T., Andrade, T. U., Pereira, T. M. C., Meyrelles, S. S., Campagnaro, B. P., & Vasquez, E. C. (2015). Chronic administration of the probiotic kefir improves the endothelial function in spontaneously hypertensive rats. Journal of Translational Medicine, 13, 390. https://doi.org/10.1186/s12967-015-0759-7.
- Gao, J., Ding, G., Li, Q., Gong, L., Huang, J., & Sang, Y. (2019). Tibet kefir milk decreases fat deposition by regulating the gut microbiota and gene expression of Lpl and Angptl 4 in high fat diet-fed rats. Food Research International, 121, 278–287. https://doi.org/10.1016/j.foodres.2019.03.029
- Gómez-Guzmán, M., Toral, M., Romero, M., Jiménez, R., Galindo, P., Sánchez, M., Zarzuelo, M., Olivares, M., Gálvez, J., & Duarte, J. (2015). Antihypertensive effects of probiotics Lactobacillus strains in spontaneously hypertensive rats. Molecular Nutrition & Food Research, 59, 2326–2336. https://doi.org/10.1002/mnfr.201500290
- Hadisaputro, S., Djokomoeljanto, R. R. J., Judiono, & Soesatyo, M. H. N. E. (2012). The effects of oral plain kefir supplementation on proinflammatory cytokine properties of the hyperglycemia Wistar rats induced by streptozotocin. Acta Medica Indonesiana, 44(2), 100–104. https://pubmed.ncbi.nlm.nih.gov/22745139
- Hao, R., Liu, Q., Wang, L., Jian, W., Cheng, Y., Zhang, Q., Hayer, K., Kamarudin, R., Idris, R., Zhang, Y., Lu, H., & Tu, Z. (2023). Anti-inflammatory effect of Lactiplantibacillus plantarum T1 cell- free supernatants through suppression of oxidative stress and NF-κB- and MAPK-signaling pathways. Applied and Environmental Microbiology, 89, e00608-23. https://doi.org/10.1128/aem.00608-23
- Hariri, M., Salehi, R., Feizi, A., Mirlohi, M., Kamali, S., & Ghiasvand, R. (2015). The effect of probiotic soy milk and soy milk on anthropometric measures and blood pressure in patients with type II diabetes mellitus: a randomized double-blind clinical trial. ARYA Atherosclerosis, 11(Suppl 1), 74–80. https://pmc.ncbi.nlm.nih.gov/articles/PMC4530661
- Harisa, G., Taha, E., Khalil, A., & Salem, M. (2009). Oral administration of Lactobacillus acidophilus restores nitric oxide level in diabetic rats. Australian Journal of Basic and Applied Sciences, 3(3), 2963–2969.
- Judiono, J., Hadisaputro, S., Ks, I., Cahyono, B., & Suzery, M. (2014). Effects of clear kefir on biomolecular aspects of glycemic status of type 2 diabetes mellitus (T2DM) patients in Bandung, West Java [Study on human blood glucose, c peptide and insulin]. Functional Foods in Health and Disease, 4, 340–348. https://doi.org/10.31989/ffhd.v4i8.145
- Katsiki, N., Mikhailidis, D., & Mantzoros, C. (2016). Non-alcoholic fatty liver disease and dyslipidemia: An update. Metabolism, 65, 1109–1123. https://doi.org/10.1016/j.metabol.2016.05.003
- Kim, D. H., Kim, H., Jeong, D., Kang, I. B., Chon, J. W., Kim, H. S., Song, K. Y., & Seo, K. H. (2017). Kefir alleviates obesity and hepatic steatosis in high-fat diet-fed mice by modulation of gut microbiota and mycobiota: targeted and untargeted community analysis with correlation of biomarkers. Journal of Nutritional Biochemistry, 44, 35–43. https://doi.org/10.1016/j.jnutbio.2017.02.014
- Kim, S. H., Cho, Y. K., Kim, Y. J., Jung, C. H., Lee, W. J., Park, J. Y., Huh, J. H., Kang, J. G., Lee, S. J., & Ihm, S. (2022). Association of the atherogenic index of plasma with cardiovascular risk beyond the traditional risk factors: A nationwide population-based cohort study. Cardiovascular Diabetology, 21, 81. https://doi.org/10.1186/s12933-022-01522-8
- Kobayashi, T., Taguchi, K., Yasuhiro, T., Matsumoto, T., & Kamata, K. (2004). Impairment of PI3-K/Akt pathway underlies attenuated endothelial function in aorta of type 2 diabetic mouse model. Hypertension, 44(6), 956–962. https://doi.org/10.1161/01.HYP.0000147559.10261.a7
- Kopin, L., & Lowenstein, C. (2017). Dyslipidemia. Annals of Internal Medicine, 167, ITC81–ITC96. https://doi.org/10.7326/aitc201712050
- Lye, H., Rusul, G., & Liong, M. (2010). Removal of cholesterol by Lactobacilli via incorporation and conversion to coprostanol. Journal of Dairy Science, 93, 1383–1392. https://doi.org/10.3168/jds.2009-2574
- Malik, M., Suboc, T. M., Tyagi, S., Salzman, N., Wang, J., Ying, R., Tanner, M. J., Kakarla, M., Baker, J. E., & Widlansky, M. E. (2018). Lactobacillus plantarum 299v supplementation improves vascular endothelial function and reduces inflammatory biomarkers in med with stable coronary artery disease. Circulation Research, 123(9), 1091–1102. https://doi.org/10.1161/circresaha.118.313565
- Mazloom, Z., Yousefinejad, A., & Dabbaghmanesh, M. (2013). Effect of probiotics on lipid profile, glycemic control, insulin action, oxidative stress, and inflammatory markers in patients with type 2 diabetes: A clinical trial. Iranian Journal of Medical Science, 38(1), 38–43. https://pubmed.ncbi.nlm.nih.gov/23645956
- Mehta, D., Ravindran, K., & Kuebler, W. (2014). Novel regulators of endothelial barrier function. American Journal of Physiology, 307(12), L924–L935. https://doi.org/10.1152/ajplung.00318.2014
- Miremadi, F., Ayyash, M., Sherkat, F., & Stojanovska, L. (2014). Cholesterol reduction mechanisms and fatty acid composition of cellular membranes of probiotic Lactobacilli and Bifidobacteria. Journal of Functional Foods, 9, 295–305. https://doi.org/10.1016/j.jff.2014.05.002
- Mlinar, B., Marc, J., Janez, A., & Pfeifer, M. (2007). Molecular mechanisms of insulin resistance and associated diseases. Clinica Chimica Acta, 375(1–2), 20–35. https://pubmed.ncbi.nlm.nih.gov/16956601
- Mokhtar, S. S., Vanhoutte, P. M., Leung, S. W. S., Suppian, R., Yusof, M. I., & Rasool, A. H. G. (2016). Reduced nitric oxide-mediated relaxation and endothelial nitric oxide synthase expression in the tail arteries of streptozotocin-induced diabetic rats. European Journal of Pharmacology, 773, 78–84. https://doi.org/10.1016/j.ejphar.2016.01.013
- Mutalub, Y. B., Azemi, A. K., Suhaimi, S. Q. A., Rasool, A. H. G., Tang, S. P., Lee, C-C., & Mokhtar, S. S. (2025). AB-kefir modulates gut microbiota and ameliorates obesity, metabolic and vascular insulin resistance in high-fat diet-induced obese rats. Journal of Functional Foods, 128, 106802. https://doi.org/10.1016/j.jff.2025.106802
- Olas, B. (2020). Probiotics, prebiotics and symbiotics – A promising strategy in prevention and treatment of cardiovascular diseases? International Journal of Molecular Sciences, 21, 9737. https://doi.org/10.3390/ijms21249737
- Ostadrahimi, A., Taghizadeh, A., Mobasseri, M., Farrin, N., Payahoo, L., & Beyramalipoor, G. Z. (2015). Effect of probiotic fermented milk (kefir) on glycemic control and lipid profile in type 2 diabetic patients: A randomized double-blind placebo-controlled clinical trial. Iranian Journal of Public Health, 44(2), 228–237. https://pubmed.ncbi.nlm.nih.gov/25905057
- Peluzio, M., Dias, M., Martinez, J., & Milagro, F. I. (2021). Kefir and intestinal microbiota modulation: Implications in human health. Frontiers in Nutrition, 8, 638740. https://doi.org/10.3389/fnut.2021.638740
- Pimenta, F. S., Luaces-Regueira, M., Ton, A. M., Campagnaro, B. P., Manue, C.-T., Pereira, T. M., & Vasquez, E. C. (2018). Mechanisms of action of kefir in chronic cardiovascular and metabolic diseases. Cellular Physiology and Biochemistry, 48(5), 1901–1914. https://doi.org/10.1159/000492511
- Qaisrani, Z. N., Lin, W. P., Lay, B. B., Phyo, K. Y., San, M. M., Awaeloh, N., Aunsorn, S., Pattanayaiying, R., Ayudthaya, P. S. N., Hongkulsup, C., Buntin, N., & Chusri, S. (2025). The impact of kefir consumption on inflammation, oxidative stress status, and metabolic-syndrome-related parameters in animal models: A systematic review and meta-analysis. Foods, 14(12), 2077. https://doi.org/10.3390/foods14122077
- Rosa, D. D., Grześkowiak, L. M., Ferreira, C. L. L. F., Fonseca, A. C. M., Reis, S. A., Dias, M. M., Siqueira, N. P., Silva, L. L., Neves, C. A., Oliveira, L. L., MacHado, A. B. F., & Peluzio, M. D. C. G. (2016). Kefir reduces insulin resistance and inflammatory cytokine expression in an animal model of metabolic syndrome. Food & Function, 7(8), 3390–3401. https://doi.org/10.1039/c6fo00339g
- Rosa, D. D., Dias, M. M. S., Grześkowiak, Ł. M., Reis, S. A., Conceição, L. L., & Peluzio, C. G. (2017). Milk kefir: Nutritional, microbiological and health benefits. Nutrition Research Reviews, 30(1), 82–96. https://doi.org/10.1017/S0954422416000275
- Samah, S., Ramasamy, K., Meng, S., & Fen, C. (2016). Probiotics for the management of type 2 diabetes mellitus: A systematic review and meta-analysis. Diabetes Research and Clinical Practice, 118, 172–182. https://doi.org/10.1016/j.diabres.2016.06.014
- Shehata, M., El Sohaimy, S., El-Sahn, M., & Youssef, M. (2016). Screening of isolated potential probiotic lactic acid bacteria for cholesterol lowering property and bile salt hydrolase activity. Annals of Agricultural Sciences, 61(1), 65–75. https://doi.org/10.1016/j.aoas.2016.03.001
- Silva, de A. M., Mowry, E. F., Peaden, C. S., Andrade, U. T., & Biancardi, C. V. (2020). Kefir ameliorates hypertension via gut–brain mechanisms in spontaneously hypertensive rats. Journal of Nutritional Biochemistry, 77, 108318. https://doi.org/10.1016/j.jnutbio.2019.108318
- Sotoudeh, N., & Namavar, M. R. (2022). Optimisation of ketamine-xylazine anaesthetic dose and its association with changes in the dendritic spine of CA1 hippocampus in the young and old male and female Wistar rats. Veterinary Medicine and Science, 8(6), 2545–2552. https://doi.org/10.1002/vms3.936
- St-Onge, M., Farnworth, E., & Jones, P. (2000). Consumption of fermented and nonfermented dairy products: effects on cholesterol concentrations and metabolism. American Journal of Clinical Nutrition, 71(3), 674–681. https://doi.org/10.1093/ajcn/71.3.674
- St-Onge, M.-P., Farnworth, E. R., Savard, T., Chabot, D., Mafu, A., & Jones, P. J. H. (2002). Kefir consumption does not alter plasma lipid levels or cholesterol fractional synthesis rates relative to milk in hyperlipidemic men: A randomized controlled trial. BMC Complementary and Alternative Medicine, 2, 1–7. https://doi.org/10.1186/1472-6882-2-1
- Sun, J., & Buys, N. (2015). Effects of probiotics consumption on lowering lipids and CVD risk factors: a systematic review and meta-analysis of randomized controlled trials. Annals of Medicine, 47(6), 430–440. https://doi.org/10.3109/07853890.2015.1071872
- Tenorio-Jimenez, C., Martinez-Ramirez, M. J., Tercero-Lozano, M., Arraiza-Irigoyen, C., Del Castillo-Codes, I., Olza, J., Plaza-Diaz, J., Fontana, L., Migueles, J. H., & Olivares, M. (2018). Evaluation of the effect of Lactobacillus reuteri V3401 on biomarkers of inflammation, cardiovascular risk and liver steatosis in obese adults with metabolic syndrome: A randomized clinical trial (PROSIR). BMC Complementary and Alternative Medicine, 18(1), 306. https://pubmed.ncbi.nlm.nih.gov/30453950
- Toral, M., Gómez-Guzmán, M., & Jiménez, R. (2014). The probiotic Lactobacillus coryniformis CECT5711 reduces the vascular pro-oxidant and pro-inflammatory status in obese mice. Clinical Science, 127(1), 33–45. https://pubmed.ncbi.nlm.nih.gov/24410749
- Tripolt, N. J., Leber, B., Blattl, D., Eder, M., Wonisch, W., Scharnagl, H., & Stojakovic, T. (2013). Effect of supplementation with Lactobacillus casei on insulin sensitivity, β-cell function, and markers of endothelial function and inflammation in subjects with metabolic syndrome: A pilot study. Journal of Dairy Science, 96(1), 89–95. https://doi.org/10.3168/jds.2012-5863
- Tseng, C., & Chu, Y. (2025). Probiotics and phytoantioxidants target coronary endothelial dysfunction in irregular sleep- and obesity-associated cardiometabolic syndrome. Life, 15(11), 1740. https://doi.org/10.3390/life15111740
- Tung, Y.-T., Chen, H.-L., Wu, H.-S., Ho, M.-H., Chong, K.-Y., & Chen, C.-M. (2017). Kefir peptides prevent hyperlipidemia and obesity in high fat diet-induced obese rats via lipid metabolism modulation. Molecular Nutrition & Food Research, 62(3), 1700505. https://doi.org/10.1002/mnfr.201700505
- Underwood, W., & Anthony, R. (2020). AVMA guidelines for the euthanasia of animals: 2020 edition. American Veterinary Medical Association.
- Urdaneta, E., Barrenetxe, J., Aranguren, P., Irigoyen, A., Marzo, F., & Ibáñez, FC. (2007). Intestinal beneficial effects of kefir-supplemented diet in rats. Nutrition Research, 27(10), 653–658. https://doi.org/10.1016/j.nutres.2007.08.002
- Vasquez, E. C., Pereira, T. M. C., Campos-Toimil, M., Baldo, M. P., & Peotta, V. A. (2019). Gut microbiota, diet, and chronic diseases: The role played by oxidative stress. Oxidative Medicine and Cellular Longevity, 2019, 1–3. https://doi.org/10.1155/2019/7092032
- Vieira, C. P., Rosario, A. I. L. S., Lelis, C. A., Rekowsky, B. S. S., Carvalho, A. P. A., Rosário, D. K. A., Elias, T. A., Costa, M. P., Foguel, D., & Conte-Junior, C. A. (2021). Bioactive compounds from kefir and their potential benefits on health: A systematic review and meta-analysis. Oxidative Medicine and Cellular Longevity, 2021(1), 9081738. https://doi.org/10.1155/2021/9081738
- Vitheejongjaroen, P., Kasorn, A., Puttarat, N., Loison, F., & Taweechotipatr, M. (2022). Bifidobacterium animalis MSMC83 improves oxidative stress and gut microbiota in D-galactose-induced rats. Antioxidants, 11, 2146. https://doi.org/10.3390/antiox11112146
- Yadav, R., Khan, S. H., Mada, S. B., Meena, S., Kapila, R., & Kaila, S. (2019). Consumption of probiotic Lactobacillus fermentum MTCC: 5898-fermented milk attenuates dyslipidemia, oxidative stress, and inflammation in male rats fed on cholesterol-enriched diet. Probiotics and Antimicrobial Protein, 11, 509–518. https://doi.org/10.1007/s12602-018-9429-4
- Yilmaz, I., & Arslan, B. (2022). The effect of kefir consumption on the lipid profile for individuals with normal and dyslipidemic properties: A randomized controlled trial. Revista de Nutricao, 35, 210098. https://doi.org/10.1590/1678-9865202235e210098
- Yusuf, D., Nuraida, L., Dewanti-hariyadi, R., & Hunaefi, D. (2020). In vitro characterization of lactic acid bacteria from Indonesian kefir grains as probiotics with cholesterol-lowering effect. Journal of Microbiology and Biotechnology, 30(5), 726–732. https://doi.org/10.4014/jmb.1910.10028
- Zhang, Y., Du, R., Wang, L., & Zhang, H. (2010). The antioxidative effects of probiotic Lactobacillus casei Zhang on the hyperlipidemic rats. European Food Research and Technology, 231, 151–158. https://doi.org/10.1007/s00217-010-1255-1
DOI: https://doi.org/10.2478/aoas-2026-0028 | Journal eISSN: 2300-8733 (formerly 1642-3402) | Journal ISSN: 1642-3402
Language: English
Submitted on: Mar 1, 2026
Accepted on: Sep 22, 2026
Published on: Nov 11, 2026
Published by: National Research Institute of Animal Production
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2026 Yahkub Babatunde Mutalub, Ahmad Khusairi Azemi, Aida Hanum Ghulam Rasool, Tang Suk Peng, Lee Chia Chia, Siti Safiah Mokhtar, published by National Research Institute of Animal Production
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.